Navigation Links
Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
Date:10/25/2010

VIENNA, Oct. 25 /PRNewswire-FirstCall/ -- Intercell AG (VSE: ICLL) today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine candidate (IC43) against infections with the bacterium Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic resistance and hence a very high unmet medical need.

In the randomized, controlled Phase II clinical trial (33 sites in 8 countries), about 400 mechanically ventilated intensive care patients, who are at particular high risk of acquiring severe and often life-threatening forms of Pseudomonas aeruginosa infections, such as Ventilator-Associated Pneumonia (VAP), sepsis or soft tissue infection were vaccinated on days zero and seven in four treatment groups  receiving 100 or 200mcg alum-adjuvanted vaccine, 100mcg non-adjuvanted vaccine or alum as placebo control.

The primary endpoint of the study was met in that all vaccine groups showed good seroconversion rates (65 - 81%) with IgG antibody Geometric Mean Titers (GMTs) (995-2117 ELISA units/ml). There were no significant differences in treatment emergent adverse events between the treatment arms and local and systemic tolerability appeared to be good, as far as assessable in this study population. The number and nature of reported drug related adverse events does not raise any safety concern and has been confirmed earlier by a Data Safety Monitoring Board (DSMB) based on interim data.

Secondary immunogenicity endpoints were also met in this study and included IgG response assessed seven times over a period of 90 days, measurement of functional antibody activity by opsonophagocytosis assay, and measurement of antibody avidity.

Overall robust immunogenicity following second vaccination was observed in all vaccine groups. A dose-response could be observed, whereas alum did not show a clear immune-enhancing effect. Antibody avid
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
2. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
3. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
4. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
5. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
6. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
7. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
8. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
9. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
10. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
11. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... -- Today, the Pharmaceutical Research and Manufacturers of ... companies as "We Work For Health Champions" for ... service. Established in 2009, the We ... the biopharmaceutical industry to honor employees who have ... also shown an outstanding commitment to their communities ...
(Date:4/17/2015)... --   IBA Molecular, a global leader in the ... has signed a definitive agreement to sell its U.S. ... Health and Science (IHS). Under IHS ownership, IBAM NA ... in Dulles, Virginia , and will ... and footprint synergies. IBA Molecular is jointly owned by ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has announced ... in 2014 - a Perspective of Mental Health Patient ... For the first time, in 2014, the ... the pharmaceutical industry held by patient groups with an ... organisations representing all therapy areas. - Findings ...
Breaking Medicine Technology:PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... April 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced ... 2 trial of the triplet combination of ... be,presented at the 98th annual meeting of ... Los Angeles. Preclinical studies of,cellular and molecular ...
... BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Apr 11, 2007 - ... that scientists from the company will present ... seliciclib, the company's,most advanced drug candidates in ... two poster presentations during the upcoming,Annual Meeting ...
Cached Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 2Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 3Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 4
(Date:4/17/2015)... Rosetta Radiology is proud to now ... list of diagnostic imaging services. This solidifies them as ... Upper East Side of Manhattan. , The new imaging ... addition of PET-CT, combined with Rosetta’s state of the ... work with patients through several stages of the cancer ...
(Date:4/17/2015)... April 17, 2015 Alcohol and Violence ... (NCADD) notes that drinking and driving has been the ... the same time, the link between alcohol and crime ... abuse and violence and sexual assault, and their relationship ... the NCADD, 5.3 million adults in America were drinking ...
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The Last ... empowered young people to create meaningful change in their world. ... and the Gospel to all of Liberia by 2020 , ... 27, students, faculty and staff raised $21,000 through the TEN ... the Good News of Jesus. , During the campaign, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Representatives Jim ... Diagnoses and Treatment Act HR 1849 in congress on ... rates and treatment for patients with the genetic disease. ... the past, would be the first to create a ... appropriate treatment of hereditary hemorrhagic telangiectasia. This would effectively ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 At the ... EcoLuxe Lounge and the “Salute to the Oscars” in ... Beverly Hilton Hotel, overlooking the impressive Los Angeles skyline. ... organized by Debbie Durkin, LA’s leading producer of sustainable ... many of the world’s premier providers of eco-friendly and ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2
... Featured in Songs that,Celebrate Motherhood and Assist Moms During ... Tunes, a new,compilation CD consisting of soothing music by ... motherhood and helps women relax while,preparing for and giving ... Dimes. Proceeds from the sale of the CD will ...
... author of NutriPoints and creator of the new, NutriHeros and NutriGrades ... Healthy Kids Vending initiative targeting schools ... around the U.S., ... Roy Vartabedian has agreed today to endorse the New Kids Healthy,Vending program ...
... Inc. (NYSE: BKD ) announced today that it ... the market closes on Wednesday, May 7,2008. The Company ... on,Thursday, May 8, 2008 at 8:00 AM ET. The ... within the U.S.) or (706) 634-9069 (from,outside of the ...
... Parents Lose ... Insurance, ... Cincinnati Children,s Hospital Medical Center point to the,negative impact of parental ... insurance coverage to meet,children,s healthcare needs and reduce healthcare disparities., ...
... Two Asthma Studies at Cincinnati Children,s Will Present ... Insights and Ways to Address Asthma at PAS, CINCINNATI, ... adolescents and younger children improve their asthma,control will be presented ... annual meeting of the Pediatric,Academic Society (PAS) in Honolulu, Hawaii., ...
... provide treatments to eligible Medicaid members, PHOENIX, ... Bill 1418 into law, allowing the state Medicaid ... to its eligible,members., Introduced by Sen. Barbara ... whatsoever on the state,s General Fund and will ...
Cached Medicine News:Health News:Top Music Artists Contribute to New CD for Moms to Benefit March of Dimes 2Health News:New York Times Best Selling Author Dr. Roy Vartabedian to Endorse New YoNaturals Kids Healthy Vending Program 2Health News:New York Times Best Selling Author Dr. Roy Vartabedian to Endorse New YoNaturals Kids Healthy Vending Program 3Health News:Brookdale Announces First Quarter 2008 Release and Earnings Call 2Health News:U.S. Unemployment Having Impact on Kids' Health Care Coverage - and That Puts Their Health at Risk 2Health News:U.S. Unemployment Having Impact on Kids' Health Care Coverage - and That Puts Their Health at Risk 3Health News:Overcoming 'I'm in Control Syndrome' and Providing Help When Patients Least Expect It Can Benefit Children and Teens With Asthma 2Health News:Overcoming 'I'm in Control Syndrome' and Providing Help When Patients Least Expect It Can Benefit Children and Teens With Asthma 3Health News:Governor Napolitano Signs Smoking Cessation Bill 2
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
OmniAccess&trade Hip Retractor System sets a new standard in hip exposure. It provides constant, absolute exposure of the acetabulum during total hip arthroplasty and revision procedures....
... Titanium tapered stems have been clinically ... SUMMIT Tapered Hip System is an advanced ... draws from DePuy's heritage as the leader ... has its foundation in critical anatomical analysis, ...
... Tunnel Release System is a single-portal system consisting ... used in conjunction with a sharp single use ... longitudinal slot to provide unsurpassed visual control with ... The system includes a set of dilators and ...
Medicine Products: